Alberto Tolcachier
Publications by Year
Research Areas
Asthma and respiratory diseases, IL-33, ST2, and ILC Pathways, Allergic Rhinitis and Sensitization, Sinusitis and nasal conditions, Respiratory and Cough-Related Research
Most-Cited Works
- → Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial(2018)299 cited
- → Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study(2023)14 cited
- → Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study(2022)10 cited
- → Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study(2024)3 cited
- → Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study(2023)